病例系列：高效合成阿片类药物使用者快速诱导长效丁丙诺啡注射。
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.
机构信息
Division on Substance Use Disorders, New York State Psychiatric Institute, New York, New York.
Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
出版信息
Am J Addict. 2020 Jul;29(4):345-348. doi: 10.1111/ajad.13018. Epub 2020 Mar 13.
Abstract
BACKGROUND AND OBJECTIVES
Highly potent synthetic opioids (HPSO) are increasingly responsible for opioid overdose deaths in the United States.
METHODS
In an open-label, uncontrolled trial to test the feasibility of extended-release buprenorphine (BXR) injection treatment of heroin-using individuals with opioid use disorder testing positive for HPSO, participants were enrolled and began an induction with sublingual BXR (n = 5). During the induction, ancillary medications (clonidine, clonazepam, zolpidem, and prochlorperazine) were provided for breakthrough opioid withdrawal symptoms.
RESULTS
Two participants received the BXR injection on the second day of the induction and three participants on the third day.
DISCUSSION AND CONCLUSION
All five participants were retained at least 1-month postinduction.
SCIENTIFIC SIGNIFICANCE
It may be feasible to provide BXR treatment to HPSO-positive heroin users rapidly to achieve clinical stabilization. (Am J Addict 2020;00:00-00).
摘要
背景与目的
在美国，高活性合成阿片类药物（HPSO）越来越多地导致阿片类药物过量死亡。
方法
在一项开放性、非对照试验中，我们测试了使用经 HPSO 检测呈阳性的海洛因使用者的延长释放丁丙诺啡（BXR）注射治疗的可行性，招募了参与者并开始使用舌下 BXR 诱导（n=5）。在诱导过程中，提供了辅助药物（可乐定、氯硝西泮、唑吡坦和丙氯拉嗪）来缓解突破性阿片类戒断症状。
结果
两名参与者在诱导的第二天接受了 BXR 注射，三名参与者在第三天接受了 BXR 注射。
讨论与结论
所有五名参与者在诱导后至少 1 个月内都被保留下来。
科学意义
快速向 HPSO 阳性的海洛因使用者提供 BXR 治疗以实现临床稳定可能是可行的。
相似文献
1
Case Series: Rapid Induction Onto Long Acting Buprenorphine Injection for High Potency Synthetic Opioid Users.病例系列：高效合成阿片类药物使用者快速诱导长效丁丙诺啡注射。
Am J Addict. 2020 Jul;29(4):345-348. doi: 10.1111/ajad.13018. Epub 2020 Mar 13.
2
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.丁丙诺啡缓释注射单日内诱导用于海洛因和芬太尼使用者的开放性试验。
Am J Addict. 2021 Sep;30(5):470-476. doi: 10.1111/ajad.13193. Epub 2021 Jul 5.
3
A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder.为期一周的门诊 XR-纳曲酮诱导治疗，用于治疗阿片类药物使用障碍患者。
Am J Drug Alcohol Abuse. 2020 May 3;46(3):289-296. doi: 10.1080/00952990.2019.1700265. Epub 2019 Dec 20.
4
A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.前瞻性、随机、多中心的直接丁丙诺啡/纳洛酮诱导海洛因依赖者的可接受性和安全性研究。
Addiction. 2012 Jan;107(1):142-51. doi: 10.1111/j.1360-0443.2011.03577.x. Epub 2011 Oct 12.
5
Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.门诊中从阿片类药物使用转为使用纳曲酮延长释放制剂时的戒断严重程度和早期治疗反应。
Am J Addict. 2018 Sep;27(6):471-476. doi: 10.1111/ajad.12763. Epub 2018 Jul 20.
6
Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.麻醉辅助与丁丙诺啡或可乐定辅助的海洛因脱毒及纳曲酮诱导：一项随机试验
JAMA. 2005 Aug 24;294(8):903-13. doi: 10.1001/jama.294.8.903.
7
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.门诊患者向阿片类药物使用障碍患者过渡使用长效纳曲酮注射剂：一项 3 期随机试验。
Drug Alcohol Depend. 2018 Jun 1;187:171-178. doi: 10.1016/j.drugalcdep.2018.02.023. Epub 2018 Apr 10.
8
Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.从丁丙诺啡转换为丁丙诺啡/纳洛酮在意大利戒毒治疗中心的安全性和耐受性。
Clin Drug Investig. 2010;30 Suppl 1:27-31. doi: 10.2165/11536030-000000000-00000.
9
Rapid heroin detoxification using a single high dose of buprenorphine.使用单次高剂量丁丙诺啡进行快速海洛因脱毒治疗。
J Psychoactive Drugs. 2001 Apr-Jun;33(2):191-3. doi: 10.1080/02791072.2001.10400484.
10
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.阿片类物质使用障碍患者从丁丙诺啡向纳曲酮缓释片转换：一项评估两种转换方案的随机临床试验。
Am J Addict. 2020 Jul;29(4):313-322. doi: 10.1111/ajad.13024. Epub 2020 Apr 4.
引用本文的文献
1
Extended-release Injectable Buprenorphine Initiation in the Emergency Department.急诊科长效注射用丁丙诺啡的起始治疗
West J Emerg Med. 2025 Jul 12;26(4):888-896. doi: 10.5811/westjem.21299.
2
Initiation and Dosing of Extended-Release Buprenorphine: A Narrative Review of Emerging Approaches for Patients Who Use Fentanyl.长效释放丁丙诺啡的起始用药与剂量：对使用芬太尼患者的新兴方法的叙述性综述
Subst Abuse Rehabil. 2025 Mar 25;16:71-82. doi: 10.2147/SAR.S516138. eCollection 2025.
3
The Impact of High-Potency Synthetic Opioids on Pharmacotherapies for Opioid Use Disorder: A Scoping Review.高活性合成阿片类药物对阿片类药物使用障碍的药物治疗的影响：范围综述。
J Addict Med. 2024;18(5):499-510. doi: 10.1097/ADM.0000000000001356. Epub 2024 Aug 10.
4
Managing Opioid Withdrawal Symptoms During the Fentanyl Crisis: A Review.芬太尼危机期间阿片类药物戒断症状的管理：综述
Subst Abuse Rehabil. 2024 Apr 10;15:59-71. doi: 10.2147/SAR.S433358. eCollection 2024.
5
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population.危重症人群舌下含服丁丙诺啡的应用实践与结果
Crit Care Explor. 2024 Mar 12;6(3):e1062. doi: 10.1097/CCE.0000000000001062. eCollection 2024 Mar.
6
Postmortem toxicology findings from the Camden Opioid Research Initiative.卡姆登阿片类药物研究计划的尸检毒理学研究结果。
PLoS One. 2023 Nov 1;18(11):e0292674. doi: 10.1371/journal.pone.0292674. eCollection 2023.
7
Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial.门诊患者从包括美沙酮在内的全激动型阿片类药物转换为长效丁丙诺啡：一项多中心临床试验的病例系列研究。
J Addict Med. 2023;17(4):e232-e239. doi: 10.1097/ADM.0000000000001136. Epub 2023 Jan 26.
8
Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder.早期在急诊部门使用 7 天长效缓释丁丙诺啡治疗阿片类药物使用障碍的经验。
Acad Emerg Med. 2023 Dec;30(12):1264-1271. doi: 10.1111/acem.14782. Epub 2023 Aug 22.
9
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review.阿片类物质使用障碍和疼痛管理中丁丙诺啡的起始策略：系统评价。
Pharmacotherapy. 2022 May;42(5):411-427. doi: 10.1002/phar.2676. Epub 2022 Mar 25.
10
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanyl.丁丙诺啡缓释注射单日内诱导用于海洛因和芬太尼使用者的开放性试验。
Am J Addict. 2021 Sep;30(5):470-476. doi: 10.1111/ajad.13193. Epub 2021 Jul 5.
本文引用的文献
1
Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.药物和阿片类药物滥用相关的过量死亡-美国，2013-2017 年。
MMWR Morb Mortal Wkly Rep. 2018 Jan 4;67(5152):1419-1427. doi: 10.15585/mmwr.mm675152e1.
2
Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.2015 - 2016年美国涉及阿片类药物、可卡因和精神兴奋剂的过量用药死亡情况
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358. doi: 10.15585/mmwr.mm6712a1.
3
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review.芬太尼、芬太尼类似物和新型合成阿片类药物：全面综述。
Neuropharmacology. 2018 May 15;134(Pt A):121-132. doi: 10.1016/j.neuropharm.2017.10.016. Epub 2017 Oct 14.
4
Fentanyl Formulations in the Management of Pain: An Update.芬太尼制剂在疼痛管理中的应用：更新。
Drugs. 2017 May;77(7):747-763. doi: 10.1007/s40265-017-0727-z.
5
Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.缓释丁丙诺啡（RBP-6000）可阻断阿片类物质使用障碍患者中氢吗啡酮激发试验的阿片类效应。
J Clin Psychopharmacol. 2016 Feb;36(1):18-26. doi: 10.1097/JCP.0000000000000434.
6
Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.重复给予RBP-6000（一种新型皮下注射长效缓释丁丙诺啡制剂，用于治疗阿片类物质使用障碍）后的群体药代动力学建模
J Clin Pharmacol. 2016 Jul;56(7):806-15. doi: 10.1002/jcph.665. Epub 2016 Mar 11.
7
The fentanyl story.芬太尼的故事。
J Pain. 2014 Dec;15(12):1215-26. doi: 10.1016/j.jpain.2014.08.010.
8
Intravenous fentanyl kinetics.静脉注射芬太尼的动力学
Clin Pharmacol Ther. 1980 Jul;28(1):106-14. doi: 10.1038/clpt.1980.138.
9
Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.芬太尼类似物在μ、δ和κ阿片受体上的药理学特征。
Eur J Pharmacol. 1992 Mar 24;213(2):219-25. doi: 10.1016/0014-2999(92)90685-w.
Zotero 插件